Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Defective biological activities of high-density lipoprotein identify patients at highest risk of recurrent cardiovascular event.
Silvain J, Materne C, Zeitouni M, Procopi N, Guedeney P, Brugier D, Galier S, Lhomme M, Ponnaiah M, Guillas I, Kc P, Dahik VD, Frisdal E, Vicaut E, Lesnik P, Rahoual G, Le Goff W, Montalescot G, Kerneis M, Guerin M. Silvain J, et al. Among authors: zeitouni m. Eur J Prev Cardiol. 2024 Nov 7:zwae356. doi: 10.1093/eurjpc/zwae356. Online ahead of print. Eur J Prev Cardiol. 2024. PMID: 39506545
Anemia Acuity Effect on Transfusion Strategies in Acute Myocardial Infarction: A Secondary Analysis of the MINT Trial.
Carrier FM, Cooper HA, Portela GT, Bertolet M, Lemesle G, Prochaska M, Kim S, Alexander JH, Crozier I, Ducrocq G, Quadros AS, Bagai A, Dracoulakis M, Madan M, Brooks MM, Carson JL, Hébert PC; MINT Investigators. Carrier FM, et al. JAMA Netw Open. 2024 Nov 4;7(11):e2442361. doi: 10.1001/jamanetworkopen.2024.42361. JAMA Netw Open. 2024. PMID: 39485351 Free PMC article. Clinical Trial.
Levosimendan in Patients with Cardiogenic Shock Refractory to Dobutamine Weaning.
Zeitouni M, Dorvillius E, Sulman D, Procopi N, Beaupré F, Devos P, Barthélémy O, Rouanet S, Ferrante A, Chommeloux J, Hekimian G, Kerneis M, Silvain J, Montalescot G; ACTION Study Group. Zeitouni M, et al. Am J Cardiovasc Drugs. 2024 Oct 21. doi: 10.1007/s40256-024-00683-z. Online ahead of print. Am J Cardiovasc Drugs. 2024. PMID: 39432228
Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia : A Target Trial Emulation Using MINT Trial Data.
Portela GT, Carson JL, Swanson SA, Alexander JH, Hébert PC, Goodman SG, Steg PG, Bertolet M, Strom JB, Fergusson DA, Simon T, White HD, Cooper HA, Abbott JD, Rao SV, Chaitman BR, Fordyce CB, Lopes RD, Daneault B, Brooks MM; MINT Investigators. Portela GT, et al. Ann Intern Med. 2024 Nov;177(11):1489-1498. doi: 10.7326/M24-0571. Epub 2024 Oct 1. Ann Intern Med. 2024. PMID: 39348705 Clinical Trial.
Transforming respiratory tract infection diagnosis in the kingdom of saudi arabia through point-of-care testing: A white paper for policy makers.
Assiri AM, Alshahrani AM, Sakkijha H, AlGeer A, Zeitouni M, AlGohary M, Dhaini L, Verma R, Singh H. Assiri AM, et al. Among authors: zeitouni m. Diagn Microbiol Infect Dis. 2024 Dec;110(4):116530. doi: 10.1016/j.diagmicrobio.2024.116530. Epub 2024 Sep 13. Diagn Microbiol Infect Dis. 2024. PMID: 39321629 Free article.
Key Challenges to Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Southeast Asia, the Middle East, and North Africa: An Expert Perspective.
Günen H, Alzaabi A, Bakhatar A, Al Mutairi S, Maneechotesuwan K, Tan D, Zeitouni M, Aggarwal B, Berzanskis A, Cintra O. Günen H, et al. Among authors: zeitouni m. Adv Ther. 2024 Nov;41(11):4312-4334. doi: 10.1007/s12325-024-02954-2. Epub 2024 Sep 23. Adv Ther. 2024. PMID: 39312107 Free PMC article. Review.
Flecainide to Prevent Atrial Arrhythmia After Patent Foramen Ovale Closure: AFLOAT Study, A Randomized Clinical Trial.
Hauguel-Moreau M, Guedeney P, Dauphin C, Auffret V, Clerc JM, Marijon E, Elbaz M, Aldebert P, Beygui F, Abi Khalil W, Da Costa A, Macia JC, Elhadad S, Cayla G, Iriart X, Laredo M, Rolland T, Temmar Y, Gheorghiu ME, Brugier D, Silvain J, Hammoudi N, Duthoit G, Diallo A, Vicaut E, Montalescot G; ACTION Study Group. Hauguel-Moreau M, et al. Circulation. 2024 Nov 19;150(21):1659-1668. doi: 10.1161/CIRCULATIONAHA.124.071186. Epub 2024 Sep 2. Circulation. 2024. PMID: 39222035 Clinical Trial.
Beta-Blocker Interruption or Continuation after Myocardial Infarction.
Silvain J, Cayla G, Ferrari E, Range G, Puymirat E, Delarche N, Guedeney P, Cuisset T, Ivanes F, Lhermusier T, Petroni T, Lemesle G, Bresoles F, Labeque JN, Pommier T, Dillinger JG, Leclercq F, Boccara F, Lim P, Besseyre des Horts T, Fourme T, Jourda F, Furber A, Lattuca B, Redjimi N, Thuaire C, Deharo P, Procopi N, Dumaine R, Slama M, Payot L, El Kasty M, Aacha K, Diallo A, Vicaut E, Montalescot G; ABYSS Investigators of the ACTION Study Group. Silvain J, et al. N Engl J Med. 2024 Oct 10;391(14):1277-1286. doi: 10.1056/NEJMoa2404204. Epub 2024 Aug 30. N Engl J Med. 2024. PMID: 39213187 Clinical Trial.
Ten-year trends in characteristics, management and outcomes of patients admitted with cardiogenic shock in the ACTION-SHOCK cohort.
Sulman D, Beaupré F, Devos P, Procopi N, Kerneis M, Guedeney P, Barthélémy O, Elhadad A, Rouanet S, Brugier D, Hekimian G, Chommeloux J, Combes A, Silvain J, Collet JP, Montalescot G, Zeitouni M; ACTION group. Sulman D, et al. Among authors: zeitouni m. Arch Cardiovasc Dis. 2024 Oct;117(10):569-576. doi: 10.1016/j.acvd.2024.07.059. Epub 2024 Aug 6. Arch Cardiovasc Dis. 2024. PMID: 39153876
120 results